Recital 7, Decision_act (EU) 2022/1488

In forcesince 7 Sep 2022

On 11 April 2022, the evaluating competent authority informed the Commission that the evaluation is delayed because studies are needed to assess the criteria for the determination of endocrine-disrupting properties of K-HDO. The evaluating competent authority expects to submit the renewal assessment report to the Agency in the first quarter of 2025.